ESC 365 - Identification of patients eligible for treatment with semaglutide after an acute coronary syndrome according to guidelines recommendations

ESC2025 Premium Access

Identification of patients eligible for treatment with semaglutide after an acute coronary syndrome according to guidelines recommendations

Session: Challenges of managing obesity in cardiovascular disease

Topic: Obesity

Speaker: Doctor A. Cordero (Alicante, ES)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Alberto Cordero

Hospital San Juan de Alicante, Alicante (Spain)

4 presentations

0 follower

5 more presentations in this session

How excess fat affects cardiac electrophysiology: preclinical obesity, clinical obesity with cardiac arrhythmias and ECG features

Speaker: Doctor N. Zhang (Tianjin, CN)

Childhood adiposity affects cardiac structure, function and disease risk in later life: evidence of a causal association

Speaker: Doctor D. Du (Beijing, CN)

Beyond BMI: the predictive value of body roundness index for premature all-cause and cardiovascular mortality: a national cohort study of US adults under 65

Speaker: Doctor S. Abohashem (Boston, US)

Implications of obesity and metabolic health on coronary heart disease: an analysis of 157,159 participants in the UK Biobank

Speaker: Doctor R. Ananda (Melbourne, AU)

Adiposity-related anthropometrics, cardiovascular outcomes, and finerenone in heart failure and chronic kidney disease with type 2 diabetes: a FINE-HEART analysis

Speaker: Doctor J. Ostrominski (Boston, US)

Access the full session

Challenges of managing obesity in cardiovascular disease

Speakers: Doctor A. Cordero, Doctor N. Zhang, Doctor D. Du, Doctor S. Abohashem, Doctor R. Ananda...

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources